Luis Felipe
Callado Hernando
Publicaciones (195) Publicaciones de Luis Felipe Callado Hernando
2024
-
Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects
Translational Psychiatry, Vol. 14, Núm. 1
-
Effects of cannabidiol in post-stroke mood disorders in neonatal rats
Pediatric Research
-
Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands
Bioorganic Chemistry, Vol. 142
-
Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome
Biomedicines, Vol. 12, Núm. 1
-
Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia
Journal of Psychiatry and Neuroscience, Vol. 49, Núm. 1, pp. E35-E44
2023
-
Agonistic properties of a series of psychotropic drugs at 5-HT1A receptors in rat and human brain membranes determined by [35S]GTPγS binding assay
Pharmacological Reports, Vol. 75, Núm. 2, pp. 266-275
-
Ethanol and illicit drugs acute use and abuse as risk factors for suicide: A case–control study based on forensic autopsies in the Basque Country, Spain
Revista de Psiquiatria y Salud Mental
-
GRM2 eta GRM3 geneen adierazpenaren ebaluazioa subjektu eskizofrenikoen postmortem garuneko kortex aurrefrontalean
Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.
-
Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects
Molecular Neurobiology, Vol. 60, Núm. 8, pp. 4472-4487
-
Pathogenic Mis-splicing of CPEB4 in Schizophrenia
Biological Psychiatry, Vol. 94, Núm. 4, pp. 341-351
-
Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease
Pharmaceutics, Vol. 15, Núm. 10
-
The Matricellular Protein Hevin Is Involved in Alcohol Use Disorder
Biomolecules, Vol. 13, Núm. 2
-
The Role of the Dopamine System in Post-Stroke Mood Disorders in Newborn Rats
International Journal of Molecular Sciences, Vol. 24, Núm. 4
2022
-
Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients
Addiction Biology, Vol. 27, Núm. 6
-
Glucocorticoid receptor dysregulation underlies 5-HT2AR-dependent synaptic and behavioral deficits in a mouse neurodevelopmental disorder model
Journal of Biological Chemistry, Vol. 298, Núm. 11
-
Glutamate, Glutamatergic Drugs and Schizophrenia
Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments (Springer International Publishing), pp. 493-521
-
Molecular mechanisms underlying cannabis-induced risk of psychosis
Cannabis and the Developing Brain (Elsevier), pp. 197-242
-
NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches
International Journal of Molecular Sciences, Vol. 23, Núm. 13
2021
-
5-HT2A receptor- and M1 muscarinic acetylcholine receptor-mediated activation of Gαq/11 in postmortem dorsolateral prefrontal cortex of opiate addicts
Pharmacological Reports, Vol. 73, Núm. 4, pp. 1155-1163
-
5-HT2A receptor-mediated Gαq/11 activation in psychiatric disorders: A postmortem study
World Journal of Biological Psychiatry, Vol. 22, Núm. 7, pp. 505-515